B2M and cancer: The authors postulate that B2M LOH may serve as the initial step towards complete loss of B2M triggered by a second mutation or dysregulation event and provided experimental evidence to demonstrate that cancer cells lacking B2M expression are susceptible to elimination by NK cells15.